Google Chrome
Safari
Firefox
Edge
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Search
Article / Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Pharma's Almanac, Q4 2016, October 23, 2016
Article / Nov 01, 2019
Hovione Technology: Dry powder inhalers towards effective affordable sustainable respiratory healthcare
On Drug Delivery, November 2019
Article / Apr 30, 2010
Inhalation: Going Beyond Asthma. Interview: Peter Villax and Jason Suggett
Drug Delivery Technology, April 2010
Press Release / May 03, 2023
Hovione and H&T Presspart extend partnership to advance high efficiency device technology for Dry Powder Inhalation formulation delivery
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.
Analytical Characterization
Hovione advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.
Article / Jun 01, 2013
Bridging API manufacturing and formulation through particle design
European Industrial Pharmacy, June 2013